# ARX

## Overview
The ARX gene encodes the aristaless related homeobox protein, a transcription factor that plays a pivotal role in the development of the central nervous system and the endocrine pancreas. This protein is characterized by its paired-type homeodomain, which facilitates DNA binding, and an Aristaless domain that contributes to transcriptional regulation. ARX is crucial for the differentiation and function of GABAergic neurons and the development of pancreatic endocrine cells, influencing the balance of cell types within the islets of Langerhans. Mutations in the ARX gene are linked to a spectrum of neurological disorders, including X-linked lissencephaly with abnormal genitalia, infantile spasms, and various forms of epilepsy and intellectual disabilities. The gene's involvement in these conditions underscores its importance in neurodevelopmental processes and highlights the complexity of its regulatory functions (Friocourt2010Mutations; Bienvenu2002ARX; Xu2019Present).

## Structure
The ARX protein is a transcription factor characterized by several distinct structural features. It contains a paired-type homeodomain, which is crucial for DNA binding and consists of 60 highly conserved amino acids forming three alpha helices that interact with the DNA core sequence 'TAAT' (Cho2012Distinct). The protein also includes an Aristaless domain at the carboxyl end, which is involved in transcriptional regulation through intramolecular interactions (Mattiske2018Regulating). 

The ARX protein has four hydrophobic polyalanine tracts, which may stabilize protein-protein and protein-DNA interactions (Mattiske2018Regulating). These tracts are located at specific positions: 100-115, 144-155, 275-281, and 432-440 (Suri2007The). The protein also features a highly conserved octapeptide domain near the N-terminus, similar to the Engrailed homology repressor domain, which recruits TLE cofactor proteins for transcription repression (Mattiske2018Regulating).

Post-translational modifications, such as phosphorylation, play a significant role in modulating the ARX protein's transcriptional activity. Identified phosphorylation sites include serines 37, 67, and 174, with serine 174 being phosphorylated by protein kinase C alpha (PRKCA) (Mattiske2018Regulating). These modifications are crucial for the protein's correct transcriptional activity. The ARX protein's structure and modifications are essential for its function in brain development and its association with various neurological disorders.

## Function
The ARX gene encodes a transcription factor that plays a critical role in the development and function of the central nervous system and the endocrine pancreas. In the brain, ARX is highly expressed in the telencephalon and ventral thalamus, where it is involved in the early steps of cerebral development and patterning. It influences transcription pathways and regulates genes necessary for cognitive development, neuronal morphogenesis, and connectivity (Bienvenu2002ARX). ARX is also crucial for the development and function of GABAergic neurons, maintaining the proliferation of cortical progenitors and ensuring proper neuronal migration and differentiation (Friocourt2010Mutations).

In the endocrine pancreas, ARX is essential for the differentiation and identity of various pancreatic endocrine cells. It promotes the differentiation of alpha-cells and is involved in the regulation of cell fate within the islets of Langerhans. ARX and Pax4 cross-repress each other to direct islet subtype destiny, influencing the balance of alpha-, beta-, delta-, and gamma-cell populations (Xu2019Present). The gene's expression is regulated by several transcription factors, including Ngn3, Isl1, Nkx2.2, and Nkx6.1, which are involved in pancreatic development (Xu2019Present).

## Clinical Significance
Mutations in the ARX gene are associated with a wide range of neurological and developmental disorders. These include X-linked lissencephaly with abnormal genitalia (XLAG), characterized by severe brain malformations, intractable seizures, and a shortened lifespan (Sherr2003The; Kato2004Mutations). ARX mutations also lead to X-linked infantile spasms syndrome (ISSX), Partington syndrome, and nonsyndromic forms of mental retardation, which are marked by symptoms such as infantile spasms, mental retardation, autism, and dystonia (Sherr2003The; Nawara2006The).

The ARX gene is crucial for the development and migration of GABAergic interneurons, and its mutations can result in a variety of clinical presentations, including early infantile epileptic encephalopathy (Ohtahara syndrome) and myoclonic epilepsy (Bettella2012Early‐onset; Ekşioğlu2011A). Polyalanine expansions and missense mutations in ARX are linked to conditions like West syndrome and nonsyndromic X-linked mental retardation (Jackson2017Extensive; Nawara2006The).

The phenotypic spectrum of ARX mutations is broad, with some mutations leading to severe cortical malformations and others resulting in epilepsy and mental retardation without cortical dysplasia (Sherr2003The; Kato2004Mutations). The variability in clinical manifestations suggests that ARX mutations can lead to a range of conditions, potentially including Shapiro syndrome (Sherr2003The).

## Interactions
The ARX protein, encoded by the ARX gene, is involved in various protein-protein and protein-DNA interactions that are crucial for its function as a transcriptional regulator. ARX interacts with Groucho/transducin-like enhancer of split (TLE) cofactor proteins, particularly TLE1, through its octapeptide domain. This interaction is essential for ARX's role as a transcriptional repressor, influencing neuronal identity and differentiation (McKenzie2007Aristalessrelated). The ARX protein also forms complexes with other TLE family members, such as TLE2 and TLE4, which similarly regulate its transcriptional repression activity (McKenzie2007Aristalessrelated).

ARX is phosphorylated by protein kinase C alpha (PRKCA) at serine 174, a process facilitated by its interaction with the scaffold protein PICK1. This phosphorylation is crucial for ARX's transcriptional activity and affects its subcellular localization (Mattiske2018Regulating). The ARX protein also interacts with nucleic acids, binding to specific DNA sequences to modulate gene expression. This interaction is influenced by its structural conformation and potential protein partners, such as transcription factors or co-activators/repressors (Cho2012Distinct). These interactions collectively underscore the complex regulatory roles of ARX in neurodevelopmental processes.


## References


[1. (Sherr2003The) Elliott H. Sherr. The arx story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes. Current Opinion in Pediatrics, 15(6):567–571, December 2003. URL: http://dx.doi.org/10.1097/00008480-200312000-00004, doi:10.1097/00008480-200312000-00004. This article has 116 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/00008480-200312000-00004)

[2. (Friocourt2010Mutations) Friocourt. Mutations in arx result in several defects involving gabaergic neurons. Frontiers in Cellular Neuroscience, 2010. URL: http://dx.doi.org/10.3389/fncel.2010.00004, doi:10.3389/fncel.2010.00004. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2010.00004)

[3. (Jackson2017Extensive) Matilda R. Jackson, Kristie Lee, Tessa Mattiske, Emily J. Jaehne, Ezgi Ozturk, Bernhard T. Baune, Terence J. O’Brien, Nigel Jones, and Cheryl Shoubridge. Extensive phenotyping of two arx polyalanine expansion mutation mouse models that span clinical spectrum of intellectual disability and epilepsy. Neurobiology of Disease, 105:245–256, September 2017. URL: http://dx.doi.org/10.1016/j.nbd.2017.05.012, doi:10.1016/j.nbd.2017.05.012. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.nbd.2017.05.012)

[4. (Bienvenu2002ARX) T. Bienvenu. Arx, a novel prd-class-homeobox gene highly expressed in the telencephalon, is mutated in x-linked mental retardation. Human Molecular Genetics, 11(8):981–991, April 2002. URL: http://dx.doi.org/10.1093/hmg/11.8.981, doi:10.1093/hmg/11.8.981. This article has 221 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/11.8.981)

[5. (Ekşioğlu2011A) Yaman Z. Ekşioğlu, Amanda W. Pong, and Masanori Takeoka. A novel mutation in the aristaless domain of the arx gene leads to ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females: arx, ohtahara syndrome, psychomotor delay. Epilepsia, 52(5):984–992, March 2011. URL: http://dx.doi.org/10.1111/j.1528-1167.2011.02980.x, doi:10.1111/j.1528-1167.2011.02980.x. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1528-1167.2011.02980.x)

[6. (Suri2007The) Mohnish Suri. The phenotypic spectrum of arx mutations. Developmental Medicine &amp; Child Neurology, 47(2):133–137, February 2007. URL: http://dx.doi.org/10.1111/j.1469-8749.2005.tb01102.x, doi:10.1111/j.1469-8749.2005.tb01102.x. This article has 10 citations.](https://doi.org/10.1111/j.1469-8749.2005.tb01102.x)

[7. (Kato2004Mutations) Mitsuhiro Kato, Soma Das, Kristin Petras, Kunio Kitamura, Ken‐ichirou Morohashi, Diane N. Abuelo, Mason Barr, Dominique Bonneau, Angela F. Brady, Nancy J. Carpenter, Karen L. Cipero, Francesco Frisone, Takayuki Fukuda, Renzo Guerrini, Eri Iida, Masayuki Itoh, Amy Feldman Lewanda, Yukiko Nanba, Akira Oka, Virginia K. Proud, Pascale Saugier‐Veber, Susan L. Schelley, Angelo Selicorni, Rachel Shaner, Margherita Silengo, Fiona Stewart, Noriyuki Sugiyama, Jun Toyama, Annick Toutain, Ana Lía Vargas, Masako Yanazawa, Elaine H. Zackai, and William B. Dobyns. Mutations of arx are associated with striking pleiotropy and consistent genotype–phenotype correlation. Human Mutation, 23(2):147–159, January 2004. URL: http://dx.doi.org/10.1002/humu.10310, doi:10.1002/humu.10310. This article has 267 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.10310)

[8. (McKenzie2007Aristalessrelated) O. McKenzie, I. Ponte, M. Mangelsdorf, M. Finnis, G. Colasante, C. Shoubridge, S. Stifani, J. Gécz, and V. Broccoli. Aristaless-related homeobox gene, the gene responsible for west syndrome and related disorders, is a groucho/transducin-like enhancer of split dependent transcriptional repressor. Neuroscience, 146(1):236–247, April 2007. URL: http://dx.doi.org/10.1016/j.neuroscience.2007.01.038, doi:10.1016/j.neuroscience.2007.01.038. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neuroscience.2007.01.038)

[9. (Nawara2006The) Magdalena Nawara, Krzysztof Szczaluba, Karine Poirier, Krystyna Chrzanowska, Jacek Pilch, Jerzy Bal, Jamel Chelly, and Tadeusz Mazurczak. The arx mutations: a frequent cause of x‐linked mental retardation. American Journal of Medical Genetics Part A, 140A(7):727–732, March 2006. URL: http://dx.doi.org/10.1002/ajmg.a.31151, doi:10.1002/ajmg.a.31151. This article has 28 citations.](https://doi.org/10.1002/ajmg.a.31151)

[10. (Cho2012Distinct) Ginam Cho, MacLean P. Nasrallah, Youngshin Lim, and Jeffrey A. Golden. Distinct dna binding and transcriptional repression characteristics related to different arx mutations. neurogenetics, 13(1):23–29, January 2012. URL: http://dx.doi.org/10.1007/s10048-011-0304-7, doi:10.1007/s10048-011-0304-7. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-011-0304-7)

[11. (Mattiske2018Regulating) Tessa Mattiske, May H. Tan, Oliver Dearsley, Desiree Cloosterman, Charles S. Hii, Jozef Gécz, and Cheryl Shoubridge. Regulating transcriptional activity by phosphorylation: a new mechanism for the arx homeodomain transcription factor. PLOS ONE, 13(11):e0206914, November 2018. URL: http://dx.doi.org/10.1371/journal.pone.0206914, doi:10.1371/journal.pone.0206914. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0206914)

[12. (Bettella2012Early‐onset) E Bettella, G Di Rosa, R Polli, E Leonardi, G Tortorella, S Sartori, and A Murgia. Early‐onset epileptic encephalopathy in a girl carrying a truncating mutation of the <scp>arx</scp> gene: rethinking the <scp>arx</scp> phenotype in females. Clinical Genetics, 84(1):82–85, November 2012. URL: http://dx.doi.org/10.1111/cge.12034, doi:10.1111/cge.12034. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.12034)

[13. (Xu2019Present) Sai Xu and Ji-Ping Xu. Present status and expectation of aristaless-related homeobox (arx) in endocrine pancreas. The International Journal of Developmental Biology, 63(11–12):579–587, 2019. URL: http://dx.doi.org/10.1387/ijdb.190242sx, doi:10.1387/ijdb.190242sx. This article has 6 citations.](https://doi.org/10.1387/ijdb.190242sx)